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major comorbidities (myocardial infarction 9.7 - 19.8%, diabetes 26.2 - 36.7%, hyperten-
sion 26.6 - 44.4%). HF incidence slightly increased (range 1992-99: 1.66% - 1.82%),
while the length of stay dramatically decreased (7.3 – 5.5 days). Crude short and long-
term mortality remained essentially unchanged. Adjusted analysis showed no clinically
meaningful reduction in 30-day mortality. Long-term mortality fell in 1994, but had no fur-
ther improvement for the rest of the observation period (Table).
Conclusion: Despite significant advances in management of HF, short-term prognosis
remains unchanged, while the long-term prognosis has had no continuous improvement
since 1994. 
10:45 a.m.
885-2 The Burden of Vascular Disease in Long-Term Follow-
Up of Elderly Myocardial Infarction Survivors
Edward L. Portnay, Harlan M. Krumholz, Yun Wang, Patricia R. Hebert, Lawrence M. 
Brass, Judith Hillevi Lichtman, Yale University School of Medicine, New Haven, CT
Background: Atherosclerosis manifests itself in a variety of vascular diseases, but
research has generally focused on a single recurrent manifestation. As a result, the true
risk of a vascular event, and thus the burden of vascular disease, following myocardial
infarction (MI) may be underestimated. Our objective was to provide a national perspec-
tive of the burden of vascular events and mortality following MI among the elderly.
Methods: We examined 6-year rates of hospital readmission for ischemic stroke, heart
failure (HF), MI, and mortality among all fee-for-service Medicare patients aged > 65
years hospitalized with MI (ICD-9 410) in 1993. Unadjusted rates were calculated for
each outcome by age group (65-74, 75-84, and 85+), gender, and race (white, black,
other).
Results: There were a total of 233,845 hospitalizations (mean age 76.4 years; 56.5%
age 75+; 47.3% women, and 89.3% Caucasian). The 6-year readmission rate was 6.8%
for recurrent MI, 10.2% for HF, and 4.2% for stroke. MI, stroke, HF and death rates were
consistently higher for women than men (7.0 vs. 6.6%, 4.4 vs. 4.0%, 11.6 vs. 9.0%, and
56.3 vs. 52.7). While rates by race were similar for MI and stroke, the HF readmission
rates were highest for blacks (13.9% vs. 9.3% for others). Rates for MI and stroke
increased gradually with increasing age (5.5%, 7.4%, and 9.8% respectively for MI and
3.5%, 4.7%, and 5.6% for stroke), but increased more dramatically for HF (7.5%, 11.5%,
and 17.0%). All-cause mortality was 54.4%, and increased markedly with advancing age
(39.2%, 59.5%, and 82.3% by age group).
Conclusion: Among elderly MI survivors, the rates of recurrent MI, stroke, and HF are
considerable, especially for women. Increased age was associated with a consistent pat-
tern of greater risk for vascular outcomes. Mortality increased from 39% among the
youngest Medicare patients to 82% among the oldest Medicare patients. These results
demonstrate the importance of including multiple vascular endpoints in public health initi-
atives to reduce the recurrence of vascular disease and death in elderly MI survivors.
11:00 a.m.
885-3 Correlation Between the Extent of Diseased Vessels and 
the Incidence of In-Hospital Cardiac Mortality in Acute 
Myocardial Infarction
Yasuhiro Ishii, Hiroshi Kasanuki, Masahiro Yagi, Jun-ichi Yamaguchi, Michitaka 
Nagashima, Hiroshi Ogawa, Tetsuya Sumiyoshi, Takashi Honda, Kazuo Haze, Toshinobu 
Horie, Tokyo Women's Medical University, Tokyo, Japan, HIJC Investigators, Tokyo, 
Japan
BACKGROUND: Multi-vessel disease and high age are said to be strong predictors of
further cardiac events in ischemic heart disease. We sought to evaluate whether the
number of diseased vessels correlates with the in-hospital cardiac mortality in different
age groups of acute myocardial infarction (AMI) patients. METHODS and RESULTS: Out
of 2,177 patients undergoing emergency coronary angiography in the Japanese Acute
Myocardial Infarction (JAMI) registry (1999-2001) of 3,021 AMI patients, 2,063 patients
without left main disease were evaluated. All the patients were divided into 4 subgroups
according to the age (n=616 (<60y), 612 (60-69y), 603 (70-79y) and 232 (>or=80y)). In
the subgroups less than 80y, higher incidence of the in-hospital cardiac mortality was
observed according to the increase in the number of diseased vessels. In the elderly sub-
group (>or=80y), the incidnece was always high, regardless of the number of diseased
vessels (15/114=13%, 8/72=11% and 5/43=12% in single, double and triple vessel dis-
ease, respectively). In this elderly subgroup, the causes of cardiac mortality in single ves-
sel disease were mainly cardiac ruptures (8/15=53%), while they were mostly heart
failures in multi-vessel disease (11/13=85%). CONCLUSIONS: In AMI patients less than
80y, the in-hospital cardiac mortality increases according to the extent of diseased ves-
sels. In elderly patients (>or=80y), the incidence does not correlate with the number of
diseased vessels. 
11:15 a.m.
885-4 The Severity of Mitral Annular Calcification Is 
Associated With Prevalent Cardiovascular Disease in 
the Elderly: The Cardiovascular Health Study
Eddy Barasch, Emily K. Marino, Gregory L. Burke, Paulo H. Chaves, Teri A. Manolio, 
John S. Gottdiener, St. Francis Hospital, Stony Brook University, Roslyn, NY, CHS 
Coordinating Center, Washington University, Seattle, WA
Background: Mitral annular calcification (MAC) is associated with cardiovascular disease
(CVD). It is uncertain whether the prevalence of CVD is associated with the severity of
MAC. Aim: We hypotesize that there is an incremental association between the severity
of MAC and prevalent CVD in the elderly. Methods: In the Cardiovascular Health Study, a
prospective community based study of risk factors for CVD in subjects >/= age 65, 3929
participants (mean age 76 ± 5 yrs, 60% women) had an echo at 1994-95 visit suitable for
MAC evaluation. MAC was identified in 1640 (41.7%, mean age 77+/- 5 yrs, 61 %
women). Severity of MAC was prospectively classified as: “mild” (n = 1495) - limited
increased echodensity involving less than 1/3 of the ring; “moderate”( n= 133) - marked
echodensity involving 1/3 or more of the ring; and
“severe” (n =12) - marked echodensity involving ½ or more of ring. Moderate and severe
MAC were grouped together for analysis. Logistic regression analysis of prevalent dis-
ease at the time of the echo (table) was performed adjusting for age, gender, race, his-
tory of diabetes, hypertension, renal insufficiency, carotid stenosis >/= 25%, ankle arm
index </= 0.9, FEV1, and electrocardiographic LV mass. No MAC (n = 2389) was the
comparison group for both mild and mod/severe MAC. Conclusions: In highly adjusted
models, there is a graded association between the extent of MAC and prevalent CVD. In
the presence of moderate/severe MAC, the odds of prevalent MI, stroke, angina and con-
gestive heart failure is doubled.
11:30 a.m.
885-5 Obesity as an Independent Predictor of First Atrial 
Fibrillation in Adults Aged >65 Years
Marion E. Barnes, Yoko Miyasaka, A. Gabriela Rosales, Kent E. Bailey, James B. 
Seward, Teresa S.M. Tsang, Mayo Clinic, Rochester, MN
Background:
Obesity as a risk factor for atrial fibrillation (AF) has remained controversial. Some stud-
ies have shown that body mass index (BMI) is an independent predictor of AF, while oth-
ers have not.
Methods:
At the Mayo Clinic, 6,078 Olmsted County, MN, residents aged >65 years underwent >1
transthoracic echocardiogram during 1990-1998. For the purpose of this study, we
excluded patients with prior AF or other atrial arrhythmia, stroke, congenital heart anom-
aly, and pacemaker implantation. A random sample of 2,200 patients from a total of
4,124 eligible patients was generated. After review of the medical records, 279 patients
were excluded due to the presence of exclusion criteria not detected from the administra-
tive databases. BMI data and or follow-up information was not available in 72 patients.
The remaining 1,849 patients comprised the study population.
Results:
Of the 1,849 patients (750 male, 1099 female; mean age 75+/-7 years), 221(12%)devel-
oped AF after a mean follow up of 4.0+/-2.7 years. BMI (per 10 kg/m2, hazards ratio (HR)
1.39; 95%CI 1.070-1.79; P=0.0135) was independently predictive of AF, adjusting for age
(P<0.0001) and sex (P=0.0371). In a multivariate model, BMI remained independently
Year Crude mortality 
(%)
Adjusted mortality (Odds Ratio, 95% confidence 
interval)
30-Day 1-year 30-Day 1-year
1992 11.00 32.47 N/A N/A
1993 10.91 33.94 1.00 (referent) 1.00 (referent)
1994 10.57 31.68 0.99 (0.98 - 1.00) 0.91 (0.90 - 0.92)
1995 10.48 31.51 1.00 (0.98 - 1.01) 0.91 (0.90 - 0.92)
1996 10.30 31.42 0.99 (0.97 - 1.00) 0.91 (0.90 - 0.92)
1997 10.20 31.70 0.98 (0.97 - 0.99) 0.92 (0.92 - 0.93)
1998 10.22 31.82 0.99 (0.97 - 1.00) 0.93 (0.92 - 0.93)
1999 10.34 31.72 1.01 (1.00 - 1.02) 0.93 (0.92 - 0.94)
MAC severity Myocardial infarction
N = 415
Stroke
N = 233
Angina
N = 837
Congestive heart failure
N = 272
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Mild 1.31 (1.02, 1.68) 1.37 (0.98, 1.91) 1.01 (0.84, 1.23) 1.27 (0.92, 1.75)
Mod/Severe 2.31 (1.36, 3.92) 2.39 (1.23, 4.65) 1.86 (1.21, 1.88) 2.40 (1.30, 4.43)
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predictive of AF development (Table).
Conclusions:
BMI was an independent predictor of first AF in this study of older adults. The potential
contribution of obesity to AF development warrants special attention, given the alarming
prevalence of both these public health problems.
11:45 a.m.
885-6 Prognostic Implications of Admission Hyperglycemia in 
Elderly Patients With Acute Myocardial Infarction
Mikhail Kosiborod, Saif S. Rathore, Yongfei Wang, Silvio E. Inzucchi, Frederick A. 
Masoudi, Edward P. Havranek, JoAnne M. Foody, Harlan M. Krumholz, Yale University 
School of Medicine, New Haven, CT, Denver Health Medical Center, Denver, CO
Background: Prior reports suggested that hyperglycemia is associated with poor out-
comes in patients (pts) with acute myocardial infarction (AMI), but were limited by size
and geographic constraints. We sought to examine the prognostic implications of hyperg-
lycemia in a large representative sample of elderly pts with AMI.
Methods: We evaluated a national sample of Medicare pts directly admitted for con-
firmed AMI between 1994-96, restricting analysis to pts >65 years with admission plasma
glucose of 50-600 mg/dL, known survival status and no terminal illness (n=142,060). Pts
were divided into quartiles (Q) based on admission glucose (Q1 50 - 119, Q2 120 - 149,
Q3 150 - 209, Q4 210-600 mg/dL). Multivariable logistic regression was used to test the
association between glucose and mortality at 30 days and 1 year.
Results: Higher glucose was associated with increased mortality at 30 days (Q1 11.4%,
Q2 14.8%, Q3 20.4%, Q4 27.1%, P<0.001) and 1 year (Q1 23.4%, Q2 27%, Q3 34.4%,
Q4 43.8%, P<0.001). This trend persisted in pts without known history of diabetes (DM)
for 30 day (Q1 11%, Q2 14.8%, Q3 22.1%, Q4 36.8%, P<0.001) and 1 year mortality (Q1
22.3%, Q2 26.4%, Q3 35.1%, Q4 52.4%, P<0.001). Adjusted mortality remained higher
in all pts with hyperglycemia, including those without prior history of DM (Table).
Conclusion: Admission hyperglycemia is associated with higher mortality in elderly pts
with AMI, including those without antecedent diagnosis of DM. Whether hyperglycemia is
a marker or mediator of higher risk is unknown.
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887-1 Combined Effects of Diastolic Dysfunction and Left 
Ventricular (LV) Remodeling on Mortality in 7,267 
Patients With Preserved LV Systolic Function
Richard V. Milani, Mandeep R. Mehra, Carl J. Lavie, Hector O. Ventura, Ochsner Clinic 
Foundation, New Orleans, LA
Background: We and others have published the adverse effects of diastolic dysfunction
(DD) and LV geometric patterns on mortality. To our knowledge the combined effects of
DD and LV remodeling has not been examined.
Methods: We assessed the impact of DD on mortality in patients with various LV struc-
tural profiles from a large echocardiographic database (n=7,267) and with normal systolic
function (EF >= 50%) (mean follow-up 3.1 years). Based on previously published criteria
utilizing relative wall thickness (RWT) (2 x posterior wall thickness / LV end diastolic
diameter; increased > 0.43), and LV mass index (LVMI) (increased > 104 g/m2 in women
and > 116 g/m2 in men), we classified patients as normal (normal RWT and LVMI), CR
(increased RWT, normal LVMI), CH (increased RWT and increased LVMI) and EH (nor-
mal RWT, increased LVMI). DD was identified based on established Doppler derived
mitral inflow patterns.
Results: The prevalence of normal cardiac structure was 54% (n=3,924), CR 35%
(n=2,543), EH 5% (n=363) and CH 6% (n=436). See figure for mortality results.
Conclusions: Cardiac remodeling in patients with preserved LV systolic function is asso-
ciated with an increase in mortality. DD nearly doubles mortality in all LV structural pro-
files and is particularly pathogenic when identified with adverse remodeling.
10:45 a.m.
887-2 Cardiogenic Shock in Patients With Preserved Left 
Ventricular Systolic Function: Characteristics and 
Insight Into Mechanisms
Krishnan Ramanathan, Shannon M. Harkness, Ambika C. Nayar, John E. Cosmi, Lynn S. 
Sleeper, Harvey D. White, Ravin Davidoff, Judith S. Hochman, New York University 
School of Medicine, New York, NY
Background: Traditionally, very poor left ventricular (LV) function with low ejection frac-
tion (EF) is considered the hallmark necessary for developing cardiogenic shock (CS)
due to predominant LV failure in acute myocardial infarction (MI). In the SHOCK trial,
patients with preserved (LVEF) developed CS, challenging this paradigm. We report the
clinical and 2-D echocardiographic (Echo) characteristics of patients with preserved
LVEF in the SHOCK trial and suggest a mechanism for CS post-MI.
Methods: We retrospectively studied SHOCK trial (n=97) patients who had core lab
assessment of Echo performed at the time of randomization and before revasculariza-
tion, excluding patients with a mechanical cause of CS. The patients were subdivided
into quartiles (Q1 to 4) based upon initial LVEF for comparison between Q1 (EF >37%;
n=24) and Q2-4 (EF </=37%).
Results: The Q1 group had lower incidence of prior MI or history of hypertension (38
vs.73%), lower mean pulmonary wedge pressure (21 ±8 vs. 24±7mmHg; p<0.05 for both)
and a trend towards lower heart rate (94±25 vs.103±21 per min; p=0.09).
Otherwise the groups had similar baseline characteristics, thrombolytic use, peak CPK,
initial hemodynamics, cardiac index, SVR and time from CS diagnosis to LVEF measure
(median 4.8 vs.7.1h; p=0.78). The groups were similar for right ventricular size and func-
tion, remote zone wall motion score index and mitral or aortic regurgitation. In 35 patients
with measure of transmitral filling patterns, the prevalence of a restrictive filling pattern
defined as E:A ratio>2 or E:A ratio 1-2 with MDT <141msec was similar in both groups
(p=0.06). The Q1 group had significantly lower LV end-diastolic (96± 45 vs. 119± 38 ml)
and end-systolic volume and a higher proportion with normal LV size range (79 vs. 42%)
and EF (47±7 vs. 25±7%) p<0.01 for all. Although stroke volume index (SVI) was higher
in Q1 (34 ± 22 vs 21± 10ml/m2; p<0.01), it was low for all groups.
Conclusions: Patients developing CS with an EF >37% have non-dilated, small sized-
LVs. We propose that acute LV dilation is an adaptive compensation for large MIs to
maintain SV and lack of acute dilation predisposes to CS, perhaps most importantly in
association with abnormal vascular tone.
11:00 a.m.
887-3 What Proportion of Patients With Heart Failure and 
Preserved Left Ventricular Systolic Function Has an 
Elevated Plasma Concentration of B-Type Natriuretic 
Peptide?
Karen J. Hogg, Esther Rooney, Eileen Lundmark, James Christie, Edward Newman, 
David Kay, John J.V McMurray, Glasgow University, Glasgow, United Kingdom
BACKGROUND: Many patients admitted to hospital with a clinical diagnosis of “heart
failure” are found to have preserved left ventricular (LV) systolic function. There remains,
however, a great deal of uncertainty as to whether or not these patients really do have
heart failure. We have determined the proportion of such patients in which there is bio-
chemical evidence of LV compromise i.e. those who have an increased plasma concen-
tration of B type natriuretic peptide (BNP).
METHODS: 2725 near consecutive emergency admissions were screened for clinical
signs of heart failure. 167 fulfilled the criteria and had heart failure according to at least
one of the three standard heart failure classification systems (Boston, NHANES and
Framingham). Their mean age was 75 years and 56% were female. Trans-thoracic
echocardiography (TTE) was performed and plasma BNP concentrations measured. An
Multivariate clinical model for prediction of AF
Variable HR 95%CI P-value
Age, year 1.044 1.025-1.065 <0.0001
Male gender 1.344 1.014-1.781 0.0397
Valvular heart disease 1.750 1.264-2.423 0.0007
History of congestive heart failure 2.778 1.986-3.885 <0.0001
History of myocardial infarction 1.805 1.330-2.452 0.0002
Diabetes mellitus 1.208 0.800-1.822 0.3687
Hypertension 1.418 1.071-1.878 0.0147
BMI, per 10 kg/m2 1.335 1.027-1.736 0.0309
Risk ratios with 95% confidence intervals
Q1 Q2 Q3 Q4
All patients
30-day mortality 1.00-referent 1.21 (1.17, 1.27) 1.51 (1.44, 1.57) 1.93 (1.84, 2.01)
1-year mortality 1.00-referent 1.13 (1.09, 1.16) 1.31 (1.27, 1.35) 1.57 (1.52, 1.62)
Patients without diabetes
30-day mortality 1.00-referent 1.25 (1.20, 1.31) 1.59 (1.52, 1.67) 2.03 (1.92, 2.13)
1-year mortality 1.00-referent 1.15 (1.11, 1.18) 1.36 (1.32, 1.41) 1.66 (1.59, 1.73)
